Export this record

Export record to excel

File type to download

Beta version

Select record 1

ArticlesPeer ReviewedFull Text

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Author / Creator:Zalcman, Gérard, Prof ; Mazieres, Julien, Prof ; Margery, Jacques, MD ; Greillier, Laurent, MD ; Audigier-Valette, Clarisse, MD ; Moro-Sibilot, Denis, Prof ; Molinier, Olivier, MD ; Corre, Romain, MD ; Monnet, Isabelle, MD ; Gounant, Valérie, MD ; Rivière, Frédéric, MD ; Janicot, Henri, MD ; Gervais, Radj, MD ; Locher, Chrystèle, MD ; Milleron, Bernard, MD ; Tran, Quan, MSc ; Lebitasy, Marie-Paule, MD ; Morin, Franck, MSc ; Creveuil, Christian, PhD ; Parienti, Jean-Jacques, Prof ; Scherpereel, Arnaud, Prof

Publisher:England: Elsevier Ltd

Journal title:The Lancet (British edition), 2016-04, Vol.387 (10026), p.1405-1414

View online as a Library member

Export record to excel

Export this record

Export record to excel

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Refine your search